

ARUP's Laboratory Test Directory
| 0098615: HER-2/neu, Serum |
| Test Mnemonic: HER 2 | |
|
#ExistMethodology>
Methodology: Enzyme-Linked Immunosorbent Assay *ExistMethodology> #ExistPerformed> Performed: Thu *ExistPerformed> #ExistReported> Reported: 1-8 days *ExistReported> |
| Specimen Required: | |
|
#ExistCollect>
Collect: One 4 mL SST.
*ExistCollect> #ExistTransport> Transport: 1 mL serum, frozen. (Min: 0.3 mL) *ExistTransport> #ExistStability> Stability: Ambient: 4 days; Refrigerated: 3 weeks; Frozen: 1 year *ExistStability> |
|
| Reference Interval: |
| #ExistRefRange> Female: 5.1-13.5 ng/mL *ExistRefRange> |
| Interpretive Data: | |
|
#ExistInterpData>
This assay is performed using the Oncogene Science HER-2/neu Microtiter ELISA. Results obtained with different assay methods or kits cannot be used interchangeably. Serum Her -2/neu levels may not always indicate the presence or absence of malignant disease. The Her -2/neu value should be used as part of an overall clinical assessment that includes additional clinical evaluation and diagnostic tests. In metastatic breast cancer cases, 92% of patients having serum HER-2/neu of 37 µg/L or greater are tissue HER2 positive, whereas only 27% of patients having values less than 37 µg/L are tissue HER2 positive. *ExistInterpData> |
| CPT Code(s): | |
| 83950 |